Eurofins Norway

Eurofins Norway company information, Employees & Contact Information

Explore related pages

Related company profiles:

Eurofins Scientific er et internasjonalt konsern som tilbyr et unikt utvalg av analysetjenester som påvirker liv, helse og miljø for et vidt spekter av bransjer. Gruppen anses å være verdensledende innen mat, miljø og farmasøytiske produkttester samt innen agrovitenskap. Gruppen er også en av de globale uavhengige markedslederne av visse analyser og laboratorietjenester innen genomikk, farmakologi, rettsmedisin, CDMO, avanserte materialvitenskap og som støtte for kliniske studier. I tillegg er Eurofins en av de viktigste fremvoksende aktørene innen klinisk diagnostisk testing i Europa og USA. Eurofins internasjonale nettverk består av mer enn 900 laboratorier i over 60 land, med over 62.000 ansatte. Porteføljen består av mer enn 200.000 analysemetoder og mer enn 450 millioner tester utføres årlig. I 2022 hadde Eurofins 6,7 milliarder euro i omsetning. Eurofins i Norge har over 220 ansatte, hovedkontor og laboratorium i Moss og laboratorier i Oslo, Kristiansand, Klepp, Bergen, Florø, Ålesund, Trondheim, Sortland og Alta. Vi utfører kjemiske, mikrobiologiske og sensoriske laboratorieanalyser, samt prøvetaking og rådgivning innen områdene miljø, mat/fôr, landbruk og produkter/kjemikalier. Eurofins bygger virksomheten på våre grunnverdier; kundefokus, kvalitet, kompetanse, lagånd og integritet.

Company Details

Employees
192
Founded
-
Address
Møllebakken 40, Moss,1538,norway
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Moss
Looking for a particular Eurofins Norway employee's phone or email?

Eurofins Norway Questions

News

Eurofins Sustainability Services Introduces Origin ID for Cotton Traceability - Offering Unparalleled Expertise and Support for Cotton Supply Chains - Business Wire

Eurofins Sustainability Services Introduces Origin ID for Cotton Traceability - Offering Unparalleled Expertise and Support for Cotton Supply Chains Business Wire

Europe Non-Invasive Prenatal Testing Market Growth and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen - Yahoo Finance

Europe Non-Invasive Prenatal Testing Market Growth and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen Yahoo Finance

When a deal is not a done deal: Nova demands higher payment from Clinical Diagnostics (1) - DataBreaches.Net

When a deal is not a done deal: Nova demands higher payment from Clinical Diagnostics (1) DataBreaches.Net

Eurofins Successfully Prices New €500M 7.5-Year Senior Unsecured Bonds - Business Wire

Eurofins Successfully Prices New €500M 7.5-Year Senior Unsecured Bonds Business Wire

Earnings call transcript: Eurofins sees strong Q4 2024 growth, profits up 32% - Investing.com

Earnings call transcript: Eurofins sees strong Q4 2024 growth, profits up 32% Investing.com

50% upside hidden in this lab testing powerhouse: Eurofins Scientific - Sam Chipkin - Livewire Markets

50% upside hidden in this lab testing powerhouse: Eurofins Scientific - Sam Chipkin Livewire Markets

Non-Invasive Prenatal Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen - Yahoo Finance

Non-Invasive Prenatal Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen Yahoo Finance

No limits in the cloud: Insights proliferate at Eurofins Viracor - Illumina

No limits in the cloud: Insights proliferate at Eurofins Viracor Illumina

Eurofins Announces the Success of Its New Schuldschein Issuance of €500m to Refinance its 2025 Schuldschein Loans - Business Wire

Eurofins Announces the Success of Its New Schuldschein Issuance of €500m to Refinance its 2025 Schuldschein Loans Business Wire

Eurofins Generates Record Revenues in H1 2025 and Continues to Improve Its Margins and Cash Generation - Business Wire

Eurofins Generates Record Revenues in H1 2025 and Continues to Improve Its Margins and Cash Generation Business Wire

Eurofins Announces the Publication of Its 2024 Annual Report - Business Wire

Eurofins Announces the Publication of Its 2024 Annual Report Business Wire

Eurofins Delivers 6.9% Revenue Growth in Q1 2025 and Continues to Make Progress on the Build Out of Its Best-in-Class, Fully Digital Global Laboratory Network - Business Wire

Eurofins Delivers 6.9% Revenue Growth in Q1 2025 and Continues to Make Progress on the Build Out of Its Best-in-Class, Fully Digital Global Laboratory Network Business Wire

Eurofins provides further refutations to another set of baseless allegations and misleading information spread by Muddy Waters - Business Wire

Eurofins provides further refutations to another set of baseless allegations and misleading information spread by Muddy Waters Business Wire

Eurofins Announces the Completion of Its Purchase of Related Party-Owned Sites - Business Wire

Eurofins Announces the Completion of Its Purchase of Related Party-Owned Sites Business Wire

Eurofins Announces Results of Cash Audit Confirming Its FY 2023 Cash Balance and the High Integrity of Its Systems and Controls and Refutes Muddy Waters’ Allegations Regarding Transactions That Occurred Between 10 and 25 Years Ago - Business Wire

Eurofins Announces Results of Cash Audit Confirming Its FY 2023 Cash Balance and the High Integrity of Its Systems and Controls and Refutes Muddy Waters’ Allegations Regarding Transactions That Occurred Between 10 and 25 Years Ago Business Wire

Eurofins Core Business Organic Growth Accelerates Above Its Objectives in H1 2023 - Business Wire

Eurofins Core Business Organic Growth Accelerates Above Its Objectives in H1 2023 Business Wire

Eurofins Responds to Muddy Waters Report - Business Wire

Eurofins Responds to Muddy Waters Report Business Wire

Eurofins Delivers New Record Level of Revenues and Strong Margins and Cash Flow Growth in H1 2024 - Business Wire

Eurofins Delivers New Record Level of Revenues and Strong Margins and Cash Flow Growth in H1 2024 Business Wire

Eurofins launches sixth buy-back programme of its own shares - Business Wire

Eurofins launches sixth buy-back programme of its own shares Business Wire

Eurofins Confirms Profitability and Cash Flow Objectives for 2024 Leading to Higher Profit Margins in Spite of the Impact of the Post-COVID Reset of BioPharma Pipelines - Business Wire

Eurofins Confirms Profitability and Cash Flow Objectives for 2024 Leading to Higher Profit Margins in Spite of the Impact of the Post-COVID Reset of BioPharma Pipelines Business Wire

After a Very Strong 2021, Eurofins Fully Compensates for the Decline in COVID-19 Testing in 2022 and Accelerates the Build-Out of its World-Class Network - Business Wire

After a Very Strong 2021, Eurofins Fully Compensates for the Decline in COVID-19 Testing in 2022 and Accelerates the Build-Out of its World-Class Network Business Wire

Eurofins Refutes Baseless Allegations and Misleading Information Spread by Muddy Waters - Business Wire

Eurofins Refutes Baseless Allegations and Misleading Information Spread by Muddy Waters Business Wire

Eurofins Scientific: Growth, Repurchase Program, And Low Debt Make An Excellent Combination - Seeking Alpha

Eurofins Scientific: Growth, Repurchase Program, And Low Debt Make An Excellent Combination Seeking Alpha

Eurofins Achieves New Record Level of Annual Revenues While Demonstrating a Strong Increase in Margins and Cash Generation and Returns to Its Pre-COVID Profitability and Cash Flow Growth Trends - Business Wire

Eurofins Achieves New Record Level of Annual Revenues While Demonstrating a Strong Increase in Margins and Cash Generation and Returns to Its Pre-COVID Profitability and Cash Flow Growth Trends Business Wire

Eurofins Delivers Strong Margin Improvement and Cash Generation in H2 2023 and Annual Results in Line With Its 2023 Objectives. Remains Confident to Achieve Its 2027 Objectives. - Business Wire

Eurofins Delivers Strong Margin Improvement and Cash Generation in H2 2023 and Annual Results in Line With Its 2023 Objectives. Remains Confident to Achieve Its 2027 Objectives. Business Wire

Eurofins Scientific: Buy On Any Further Pullback (OTCMKTS:ERFSF) - Seeking Alpha

Eurofins Scientific: Buy On Any Further Pullback (OTCMKTS:ERFSF) Seeking Alpha

Eurofins says independent audit refutes short seller's allegations - Reuters

Eurofins says independent audit refutes short seller's allegations Reuters

Eurofins Announces the Successful Closing of Its Acquisition of SYNLAB’s Clinical Diagnostics Operations in Spain - Business Wire

Eurofins Announces the Successful Closing of Its Acquisition of SYNLAB’s Clinical Diagnostics Operations in Spain Business Wire

Muddy Waters reveals due diligence on its Eurofins short - Alternatives Watch

Muddy Waters reveals due diligence on its Eurofins short Alternatives Watch

Eurofins, other TICs dubbed ‘gatekeepers’ in wake of new Amazon dietary supplement policy - SupplySide Supplement Journal

Eurofins, other TICs dubbed ‘gatekeepers’ in wake of new Amazon dietary supplement policy SupplySide Supplement Journal

Eurofins Scientific Faces A Reality Check On Pandemic-Era Gains - Finimize

Eurofins Scientific Faces A Reality Check On Pandemic-Era Gains Finimize

You Can’t Repel Muddy Waters With Weak Credibility - Bloomberg

You Can’t Repel Muddy Waters With Weak Credibility Bloomberg

Eurofins Transplant Genomics and Viracor Will Partner to Offer Remote Sample Collection Options to Support Care for Kidney Transplant Recipients During COVID-19 Outbreak - PR Newswire

Eurofins Transplant Genomics and Viracor Will Partner to Offer Remote Sample Collection Options to Support Care for Kidney Transplant Recipients During COVID-19 Outbreak PR Newswire

The Noise Has Been Loud Lately, But At The Deepest Level Eurofins Is Unchanged (ERFSF) - Seeking Alpha

The Noise Has Been Loud Lately, But At The Deepest Level Eurofins Is Unchanged (ERFSF) Seeking Alpha

Eurofins to Acquire Majority Stake in Ajal for Laboratories, to Expand its Food and Pharmaceutical Products Testing Offering in the Kingdom of Saudi Arabia - Business Wire

Eurofins to Acquire Majority Stake in Ajal for Laboratories, to Expand its Food and Pharmaceutical Products Testing Offering in the Kingdom of Saudi Arabia Business Wire

Eurofins Scientific SE (EPA:ERF) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock? - simplywall.st

Eurofins Scientific SE (EPA:ERF) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock? simplywall.st

Luxaviation and Eurofins: A partnership to prevent SARS-Cov-2 contamination through aircraft surface testing - International Airport Review

Luxaviation and Eurofins: A partnership to prevent SARS-Cov-2 contamination through aircraft surface testing International Airport Review

Under the microscope: The challenge of quality control for adenovirus and RNA-based vaccines - European Pharmaceutical Review

Under the microscope: The challenge of quality control for adenovirus and RNA-based vaccines European Pharmaceutical Review

Eurofins to acquire Covance Food Solutions from LabCorp for $670 million - NutraIngredients.com

Eurofins to acquire Covance Food Solutions from LabCorp for $670 million NutraIngredients.com

Saudi Arabia's Non-Invasive Prenatal Testing (NIPT) Market Set to Triple by 2033: Developments, Strategies, and Financial Insights of Leading Players Eurofins Scientific, Roche, Invitae Corp., Illumina and More - GlobeNewswire

Saudi Arabia's Non-Invasive Prenatal Testing (NIPT) Market Set to Triple by 2033: Developments, Strategies, and Financial Insights of Leading Players Eurofins Scientific, Roche, Invitae Corp., Illumina and More GlobeNewswire

Eurofins Discovery Introduces Innovative DiscoveryAI SAFIRE: A New AI-Driven Platform for Drug Discovery Trained Using Proprietary Datasets - The AI Journal

Eurofins Discovery Introduces Innovative DiscoveryAI SAFIRE: A New AI-Driven Platform for Drug Discovery Trained Using Proprietary Datasets The AI Journal

Eurofins Consumer Product Testing Announces State-of-the-Art Expansion of Bangalore Laboratory - The AI Journal

Eurofins Consumer Product Testing Announces State-of-the-Art Expansion of Bangalore Laboratory The AI Journal

Characterization of a novel non-steroidal glucocorticoid receptor agonist optimized for topical treatment - Nature

Characterization of a novel non-steroidal glucocorticoid receptor agonist optimized for topical treatment Nature

Road related pollutants induced DNA damage in dragonfly nymphs (Odonata, Anisoptera) living in highway sedimentation ponds - Nature

Road related pollutants induced DNA damage in dragonfly nymphs (Odonata, Anisoptera) living in highway sedimentation ponds Nature

Eurofins expands food and water testing capabilities in Scotland - Food and Drink Technology

Eurofins expands food and water testing capabilities in Scotland Food and Drink Technology

Top 10 Sequencing Companies - Inside Precision Medicine

Top 10 Sequencing Companies Inside Precision Medicine

Eurofins First in U.S. to Earn International Olive Council Accreditation - PR Newswire

Eurofins First in U.S. to Earn International Olive Council Accreditation PR Newswire

CMA: ‘Exiting firm’ defence and speed of the CMA decision - Taylor Wessing

CMA: ‘Exiting firm’ defence and speed of the CMA decision Taylor Wessing

Eurofins birthday donation to allergy charity - Food and Drink Technology

Eurofins birthday donation to allergy charity Food and Drink Technology

Pharma-testing biz Eurofins Scientific says it fell victim to 'new version' of malware - theregister.com

Pharma-testing biz Eurofins Scientific says it fell victim to 'new version' of malware theregister.com

Twin DNA test: Why identical criminals may no longer be safe - BBC

Twin DNA test: Why identical criminals may no longer be safe BBC

GenomeTrakr: What Do You Know and What Should You Know? - FoodSafetyTech

GenomeTrakr: What Do You Know and What Should You Know? FoodSafetyTech

Lancaster Labs sold - LancasterOnline

Lancaster Labs sold LancasterOnline

Major workout supplement company halts sales after fraud exposed - Sky News Australia

Major workout supplement company halts sales after fraud exposed Sky News Australia

Top Eurofins Norway Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant